On January 7, 2020 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, reported that the Company will present an overview of the company at Biotech Showcase 2020 on Monday, January 13, 2020 in San Francisco, CA and meet with investors in 1×1 meetings throughout the day (Press release, Cytosorbents, JAN 7, 2020, View Source [SID1234552819]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Biotech Showcase 2020
Where: Hilton San Francisco Union Square, 333 O’Farrell Street, San Francisco, CA
When: Monday, January 13, 2020 from 3:00PM-3:30PM PST
Webcast: Biotech Showcase 2020 Webcast Link

A live webcast of the presentation will be available at the above webcast link. An archived replay of the webcast will be available for 90 days following the event.